Expanding the Scope of Bacterial CRISPR Activation with PAM- Flexible dCas9 Variants

被引:9
|
作者
Kiattisewee, Cholpisit [1 ,2 ]
Karanjia, Ava, V [1 ,2 ,3 ]
Legut, Mateusz [4 ,5 ]
Daniloski, Zharko [4 ,5 ,6 ]
Koplik, Samantha E. [7 ]
Nelson, Joely [1 ,2 ]
Kleinstiver, Benjamin P. [8 ,9 ,10 ]
Sanjana, Neville E. [4 ,5 ]
Carothers, James M. [1 ,2 ,3 ,7 ]
Zalatan, Jesse G. [1 ,2 ,3 ,11 ]
机构
[1] Univ Washington, Mol Engn & Sci Inst, Seattle, WA 98195 USA
[2] Univ Washington, Ctr Synthet Biol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA
[4] New York Genome Ctr, New York, NY 10013 USA
[5] NYU, Dept Biol, New York, NY 10013 USA
[6] Beam Therapeut, Cambridge, MA 02142 USA
[7] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA
[8] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA
[9] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[10] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA
[11] Univ Washington, Dept Chem, Seattle, WA 98195 USA
来源
ACS SYNTHETIC BIOLOGY | 2022年 / 11卷 / 12期
基金
美国国家科学基金会;
关键词
transcriptional regulation; engineered Cas9; PAM; CRISPRa; CRISPRi; CAS9; VARIANTS; SCREENS; NUCLEASES; KNOCKOUT; BIOLOGY;
D O I
10.1021/acssynbio.2c00405
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR-Cas transcriptional tools have been widely applied for programmable regulation of complex biological networks. In comparison to eukaryotic systems, bacterial CRISPR activation (CRISPRa) has stringent target site requirements for effective gene activation. While genes may not always have an NGG protospacer adjacent motif (PAM) at the appropriate position, PAM-flexible dCas9 variants can expand the range of targetable sites. Here we systematically evaluate a panel of PAM flexible dCas9 variants for their ability to activate bacterial genes. We observe that dxCas9-NG provides a high dynamic range of gene activation for sites with NGN PAMs while dSpRY permits modest activity across almost any PAM. Similar trends were observed for heterologous and endogenous promoters. For all variants tested, improved PAM-flexibility comes with the trade-off that CRISPRi-mediated gene repression becomes less effective. Weaker CRISPR interference (CRISPRi) gene repression can be partially rescued by expressing multiple sgRNAs to target many sites in the gene of interest. Our work provides a framework to choose the most effective dCas9 variant for a given set of gene targets, which will further expand the utility of CRISPRa/i gene regulation in bacterial systems.
引用
收藏
页码:4103 / 4112
页数:10
相关论文
共 50 条
  • [31] Live imaging and tracking of genome regions in CRISPR/dCas9 knock-in mice
    Jinzhi Duan
    Guangqing Lu
    Yu Hong
    Qingtao Hu
    Xueying Mai
    Jing Guo
    Xiaofang Si
    Fengchao Wang
    Yu Zhang
    Genome Biology, 19
  • [32] CRISPR/dCas9 Transcriptional Activation of Endogenous Apolipoprotein AI and Paraoxonase 1 in Enterocytes Alleviates Endothelial Cell Dysfunction
    Toma, Laura
    Barbalata, Teodora
    Sanda, Gabriela M.
    Niculescu, Loredan S.
    Sima, Anca V.
    Stancu, Camelia S.
    BIOMOLECULES, 2021, 11 (12)
  • [33] A new method for the robust expression and single-step purification of dCas9 for CRISPR interference/activation (CRISPRi/a) applications
    Pandey, Harshita
    Yadav, Binduma
    Shah, Koushik
    Kaur, Raminder
    Choudhary, Diksha
    Sharma, Nishtha
    Rishi, Vikas
    PROTEIN EXPRESSION AND PURIFICATION, 2024, 220
  • [34] Improved drought stress tolerance in Arabidopsis by CRISPR/dCas9 fusion with a Histone AcetylTransferase
    Joaquin Felipe Roca Paixão
    François-Xavier Gillet
    Thuanne Pires Ribeiro
    Caroline Bournaud
    Isabela Tristan Lourenço-Tessutti
    Daniel D. Noriega
    Bruno Paes de Melo
    Janice de Almeida-Engler
    Maria Fatima Grossi-de-Sa
    Scientific Reports, 9
  • [35] A study of RNA polymerase-Template interaction utilizing CRISPR/dCas9 protein
    Hogaboom, Jeremy R.
    Enkhbaatar, Khulan
    King, Maxwell J. M.
    Rohlman, Christopher E.
    FASEB JOURNAL, 2022, 36
  • [36] Inducible gene expression control using CRISPR/dCas9 and antiviral protease inhibitors
    Tague, Elliot
    Ngo, John
    PROTEIN SCIENCE, 2017, 26 : 200 - 200
  • [37] Modularized CRISPR/dCas9 Effector Toolkit for Target-Specific Gene Regulation
    Agne, Michael
    Blank, Ilona
    Emhardt, Alica J.
    Gaebelein, Christoph G.
    Gawlas, Fenja
    Gillich, Nadine
    Gonschorek, Patrick
    Juretschke, Thomas J.
    Kraemer, Stefan D.
    Louis, Natalie
    Mueller, Anne
    Rudorf, Alina
    Schaefer, Lisa M.
    Scheidmann, Manuel C.
    Schmunk, Lisa J.
    Schwenk, Philipp M.
    Stammnitz, Maximilian R.
    Warmer, Philipp M.
    Weber, Wilfried
    Fischer, Adrian
    Kaufmann, Beate
    Wagner, Hanna J.
    Radziwill, Gerald
    ACS SYNTHETIC BIOLOGY, 2014, 3 (12): : 986 - 989
  • [38] Development of CRISPR/dCas9 systems to address muscle fibrosis in Duchenne muscular dystrophy
    March, J. T.
    Dickson, G.
    Popplewell, L.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S7 - S7
  • [39] Short communication: An inducible CRISPR/dCas9 gene repression system in Lactococcus lactis
    Xiong, Zhi-Qiang
    Wei, Yun-Ying
    Kong, Ling-Hui
    Song, Xin
    Yi, Hua-Xi
    Ai, Lian-Zhong
    JOURNAL OF DAIRY SCIENCE, 2020, 103 (01) : 161 - 165
  • [40] CRISPR/dCas9 Activated Expression of Cardiomyocyte Differentiation Factors in CDCs in Myocardial Infarctions
    Sano, T.
    Ishigami, S.
    Bandaru, S.
    Ito, T.
    Sano, S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3275 - 3275